1387 related articles for article (PubMed ID: 7018190)
21. [The long-term effects of a new converting enzyme inhibitor, delapril hydrochloride, on renal function, renin-angiotensin-aldosterone system and kallikrein-kinin prostaglandin system in hypertensive patients].
Nishiyama K; Igari T; Nanba S; Ishii M
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):801-7. PubMed ID: 2273596
[TBL] [Abstract][Full Text] [Related]
22. [Changes of components in the kinin system and plasma renin activity during different stages of hypertension in patients treated with captopril].
Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Horubała-Bielak G
Pol Tyg Lek; 1994 Mar 7-14; 49(10-11):245-8. PubMed ID: 7862589
[TBL] [Abstract][Full Text] [Related]
23. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
Jiang M
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
[TBL] [Abstract][Full Text] [Related]
24. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
[TBL] [Abstract][Full Text] [Related]
25. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
[TBL] [Abstract][Full Text] [Related]
26. Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.
Karlberg BE; Asplund J; Nilsson OR; Wettre S; Ohman KP
Acta Med Scand; 1981; 209(4):245-52. PubMed ID: 7015795
[TBL] [Abstract][Full Text] [Related]
27. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
Stanek B; Silberbauer K
Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
[TBL] [Abstract][Full Text] [Related]
29. [Effect of hydrochlorothiazide on various components of the kinin system and plasma renin activity in patients with arterial hypertension treated with captopril].
Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Horubała-Bielak G
Wiad Lek; 1992 Aug; 45(15-16):569-74. PubMed ID: 1336910
[TBL] [Abstract][Full Text] [Related]
30. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
[TBL] [Abstract][Full Text] [Related]
31. [Effect of captopril on various components of the kinin system and plasma renin activity in patients with idiopathic arterial hypertension].
Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Horubała-Bielak G
Kardiol Pol; 1989; 32(3):121-30. PubMed ID: 2695682
[TBL] [Abstract][Full Text] [Related]
32. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
Säynävälammi P
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
[TBL] [Abstract][Full Text] [Related]
33. Loss of sodium modulation of plasma kinins in human hypertension.
Murphey LJ; Eccles WK; Williams GH; Brown NJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1046-52. PubMed ID: 14718610
[TBL] [Abstract][Full Text] [Related]
34. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Sellars L; Shore AC; Mott V; Wilkinson R
Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
[TBL] [Abstract][Full Text] [Related]
35. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
36. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
[No Abstract] [Full Text] [Related]
37. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
[No Abstract] [Full Text] [Related]
38. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
39. [Hypotensive effects of angiotensin I converting enzyme inhibitor, and relationship between kallikrein-kinin system and renin-angiotensin-aldosterone system].
Mizuno K; Gotoh M; Haruyama K; Ikeda K; Hashimoto S; Fukuchi S
Nihon Jinzo Gakkai Shi; 1983 Jan; 25(1):59-66. PubMed ID: 6341658
[No Abstract] [Full Text] [Related]
40. Acute changes in the renin-angiotensin-aldosterone system, catecholamines and prostaglandins during captopril in man.
Lijnen P; Verschueren LJ; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1980 Dec; 2(6):293-301. PubMed ID: 6152995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
